Aurinia Pharmaceuticals Inc. (AUPH) Operating income 2018–2025
Aurinia Pharmaceuticals Inc. (AUPH) annual operating income history from SEC filings — each fiscal year as reported.
$104.9MFY2025 · since FY2018: -$55.2M → $104.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $104.9M | +2338.4% |
| FY2024 | -$4.7M | +94.9% |
| FY2023 | -$91.7M | +17.7% |
| FY2022 | -$111.5M | +38.3% |
| FY2021 | -$180.7M | -73.3% |
| FY2020 | -$104.3M | -14.7% |
| FY2019 | -$90.9M | -64.6% |
| FY2018 | -$55.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice